India has joined the global NeoSep1 clinical trial, led by the Global Antibiotic Research and Development Partnership (GARDP), to identify safer and more effective antibiotic combinations for newborns ...

Flosonics Medical received the Paul and Debra Walker Award, part of the Sepsis Research and Innovation Challenge at the Unite for Sepsis Symposium presented by Sepsis Alliance in Washington, D.C. on ...

Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.

Clinical guidelines support lower blood pressure targets and active volume removal to mitigate fluid overload in older sepsis ...

India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic combinations for neonatal sepsis as resistance weakens standard treatments.

An effort to produce recommendations for hospitalists to treat atrial fibrillation led to a wide-ranging search for answers.

The WHO has issued its first comprehensive guidelines for managing Ebola and Marburg diseases, stressing early supportive care as Africa battles an ongoing Bundibugyo Ebola outbreak.

At the programme, the Lagos State Commissioner for Health, Akin Abayomi, a professor, stated that the state still records ...

Much of what is known about Ebola virus disease comes from outbreaks of Orthoebolavirus zairense and Orthoebolavirus sudanense. Although these provide important lessons for the current response, ...

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World Health Organization (WHO) has released its first comprehensive guidelines for ...

The NeoSep1 trial is expected to enroll 3,000 newborns across Asia and Africa by the end of 2028. ​Along with India, newborns have already been enrolled in Ghana, Kenya, and South Africa. Hospitals in ...

As debates over gender-affirming care intensify across many countries, lawmakers, physicians, and human rights advocates risk ...